| Hengqu (hetrombopag) / Jiangsu Hengrui Pharma |
NCT01830660: A Phase I Study of Hetrombopag Olamine in Healthy Adult Volunteers |
|
|
| Completed | 1 | 96 | RoW | Hetrombopag Olamine Tablets, placebo | Jiangsu HengRui Medicine Co., Ltd. | Healthy | 06/13 | 06/13 | | |
NCT02409394: Effect of a High-fat Meal on the Pharmacokinetics of Hetrombopag and Mass Balance Study in Healthy Subjects |
|
|
| Completed | 1 | 12 | RoW | Hetrombopag Olamine | Jiangsu HengRui Medicine Co., Ltd. | Healthy | 04/14 | 04/14 | | |
NCT02403440: A Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients |
|
|
| Unknown status | 1 | 24 | RoW | Hetrombopag Olamine | Jiangsu HengRui Medicine Co., Ltd. | Purpura, Thrombocytopenic, Idiopathic | 04/15 | | | |
NCT02614846: Safety and Efficacy Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients |
|
|
| Unknown status | 1 | 29 | RoW | Hetrombopag Olamine | Jiangsu HengRui Medicine Co., Ltd. | Chronic Idiopathic Thrombocytopenic Purpura | 03/16 | | | |
NCT03603132: A Study to Evaluate Different Intervals Between Dosing and Feeding on the Pharmacokinetics |
|
|
| Completed | 1 | 15 | RoW | Hetrombopag Olamine | Jiangsu HengRui Medicine Co., Ltd. | Immune Thrombocytopenia | 08/18 | 08/18 | | |
NCT03977805: Metabolism and Disposition of [14C] Herombopag in Chinese Healthy Human Subjects |
|
|
| Completed | 1 | 6 | RoW | Hetrombopag Olamine | Jiangsu HengRui Medicine Co., Ltd. | Healthy | 06/19 | 06/19 | | |
NCT04688008: Relative Bioavailability of Early Phase and Late Phase Hetrombopag Olamine Formulations |
|
|
| Completed | 1 | 58 | RoW | Hetrombopag | Jiangsu HengRui Medicine Co., Ltd. | Bioavailability Study | 10/20 | 10/20 | | |
| Completed | 1 | 26 | RoW | Hetrombopag Olamine Tablet；Ciclosporin Soft Capsule | Jiangsu HengRui Medicine Co., Ltd. | Sever Aplastic Anaemia | 10/20 | 10/20 | | |
NCT05088642: A Trial of Hetrombopag in Healthy and Hepatic Impairment Subjects |
|
|
| Completed | 1 | 24 | RoW | Hetrombopag Olamine Tablet | Jiangsu HengRui Medicine Co., Ltd. | Sever Aplastic Anaemia | 12/20 | 12/20 | | |
NCT05088343: Effect of Hetrombopag on the Pharmacokinetics of Rosuvastatin in Healthy Subjects |
|
|
| Completed | 1 | 14 | RoW | Rosuvastatin, Hetrombopag | Jiangsu HengRui Medicine Co., Ltd. | Healthy Subjects | 01/21 | 01/21 | | |
| Completed | 1 | 48 | RoW | SHR8735 | Atridia Pty Ltd. | Healthy Volunteers | 07/21 | 07/21 | | |
NCT05088655: A Bioequivalence Study of Hetrombopag in Healthy Subjects |
|
|
| Completed | 1 | 58 | RoW | Hetrombopag Olamine Tablet | Jiangsu HengRui Medicine Co., Ltd. | Sever Aplastic Anaemia | 07/22 | 11/23 | | |
NCT06062680: Study of the Food Effects of Herombopag Olamine Tablets in Healthy Subjects |
|
|
| Not yet recruiting | 1 | 15 | NA | Herombopag Olamine Tablets | Jiangsu HengRui Medicine Co., Ltd. | Adult Patients With Chronic Primary ITP, Adult Patients With SAA Who do Not Respond Well to Immunosuppressive Therapy | 11/23 | 11/23 | | |
NCT06346925: Study of the Food Effects of Herombopag Olamine Tablets in Healthy Subjects. |
|
|
| Not yet recruiting | 1 | 18 | RoW | Herombopag Olamine Tablets | Jiangsu HengRui Medicine Co., Ltd. | Adult Patients With Chronic Primary ITP, Adult Patients With SAA Who do Not Respond Well to Immunosuppressive Therapy | 07/24 | 07/24 | | |
ChiCTR2300068899: Effects Of “Huang’s Fuzheng Quxie“ Acupuncture on IL-23/IL-17 inflammatory axis in chronic spontaneous urticaria |
|
|
| Not yet recruiting | 1 | 70 | | Huang's FuzhengQuxie acupuncture was used ;Cetirizine hydrochloride tablets taken orally | Shanghai Research Institute of Acupuncture and Meridian; Shanghai Research Institute of Acupuncture and Meridian, Shanghai Municipal Health Commission | chronic urticaria | | | | |
